INT287191

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.34
First Reported 2009
Last Reported 2009
Negated 0
Speculated 1
Reported most in Body
Documents 1
Total Number 1
Disease Relevance 1.18
Pain Relevance 0.04

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

mitochondrion (BPHL) cellular amino acid metabolic process (BPHL)
BPHL (Homo sapiens)
Pain Link Frequency Relevance Heat
antagonist 27 86.52 High High
Onset of action 1 47.48 Quite Low
headache 1 5.00 Very Low Very Low Very Low
Potency 1 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Benign Prostatic Hypertrophy 101 100.00 Very High Very High Very High
Hematuria 7 99.96 Very High Very High Very High
Reprotox - General 1 13 91.20 High High
Gynecomastia 4 60.92 Quite High
Overactive Bladder 23 25.64 Quite Low
Lower Urinary Tract Symptoms 44 5.00 Very Low Very Low Very Low
Diuresis 8 5.00 Very Low Very Low Very Low
Pressure Volume 2 Under Development 4 5.00 Very Low Very Low Very Low
Incontinence 4 5.00 Very Low Very Low Very Low
Hyponatremia 4 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Recent studies demonstrate that 5-alpha-reductase inhibitors are effective in the treatment of BPH-induced hematuria,41 probably through their effect on prostate microvessel density.42 Multiple studies now support the role of short-term 5-alpha-reductase inhibitor monotherapy prior to definitive surgical resection in order to decrease hematuria during and after the procedure.43,44

5-alpha-reductase inhibitor and alpha-adrenergic receptor antagonist combination therapy

Spec (probably) Regulation (effective) of Positive_regulation (treatment) of BPH-induced associated with benign prostatic hypertrophy, antagonist and hematuria
1) Confidence 0.34 Published 2009 Journal Patient Prefer Adherence Section Body Doc Link PMC2778433 Disease Relevance 1.18 Pain Relevance 0.04

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox